Boston Scientific wins expanded FDA nod for cryoablation system

Boston Scientific (NYSE:BSX) announced today that it received expanded FDA 510(k) clearance for its Visual Ice cryoablation system.

Related Keywords

Boston , Massachusetts , United States , Peter Pattison , Boston Scientific , , Visual Ice , Interventional Oncology ,